Muhammad Adil Obaid
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Muhammad Adil Obaid has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Muhammad Ishtiaq Obaid
Department of Medicine
2 shared publications - Ahmed Kamal Siddiqi
Division of Cardiothoracic Imaging, Department of Radiology and Imaging Sciences, Emory University, Atlanta, GA, United States
1 shared publication - Areej Shakil
Department of Medicine, Jinnah Sindh Medical University, Karachi, Pakistan
1 shared publication Burhanuddin Rangwala
Jinnah Sindh Med Univ, Dept Med, Karachi, Pakistan
1 shared publication- Dayab Asad
Department of Medicine
1 shared publication - Fakhar Latif
Department of Internal Medicine, Dow University of Health Sciences, Karachi, Pakistan
1 shared publication
Latest Publications
- Open Access
- 30 September 2024
- Published by Taylor & Francis in Future Science OA
- Vol. 10 (1) , 2400797
Relationship between SGLT2 inhibitor use and specific cancer types: a systematic review and meta-analysis
Aim: The study aimed to explore the incidence of cancer as an adverse event to SGLT2 inhibitors (SGLT2i) use in Type 2 diabetes.Materials & methods: The study followed PRISMA guidelines to pool RCTs conforming the inclusion criteria. Random effects model was used to pool risk ratios.Results & conclusion: After reviewing 19 studies, the analysis suggested a possible increased risk of reproductive, breast, thyroid, hematologic/lymphatic, urinary, skin and skeletal cancers with SGLT2i use. Conversely, lower incidences of respiratory and cardiovascular cancers were noted. However, these associations lacked statistical significance. Caution is advised in using SGLT2i due to potential cancer risks, especially in diabetic patients prone to cancer. More RCTs are essential due to limited research in this area.
- 30 September 2024
- Published by Taylor & Francis in Future Science OA
- Vol. 10 (1) , 2400797
Open AccessRelationship between SGLT2 inhibitor use and specific cancer types: a systematic review and meta-analysis
Aim: The study aimed to explore the incidence of cancer as an adverse event to SGLT2 inhibitors (SGLT2i) use in Type 2 diabetes.Materials & methods: The study followed PRISMA guidelines to pool RCTs conforming the inclusion criteria. Random effects model was used to pool risk ratios.Results & conclusion: After reviewing 19 studies, the analysis suggested a possible increased risk of reproductive, breast, thyroid, hematologic/lymphatic, urinary, skin and skeletal cancers with SGLT2i use. Conversely, lower incidences of respiratory and cardiovascular cancers were noted. However, these associations lacked statistical significance. Caution is advised in using SGLT2i due to potential cancer risks, especially in diabetic patients prone to cancer. More RCTs are essential due to limited research in this area.
- Open Access
- 6 June 2024
- Published by Taylor & Francis in Future Science OA
- Vol. 10 (1) , 2359843
Analysis of attitudes and practices toward gastroesophageal reflux disease among the general population of Pakistan
This summary presents the findings of a survey conducted to gauge people's understanding, attitudes and behaviors concerning gastroesophageal reflux disease (GERD). GERD is a condition involving the movement of stomach contents back into the esophagus or mouth, which can lead to the development of symptoms or complications. Common risk factors associated with the emergence of GERD symptoms, such as heartburn and the regurgitation of stomach contents into the oropharynx, include smoking, consumption of fatty and spicy foods and meal timing. While people are aware of these risk factors and the signs of GERD, many do not take proactive steps to seek medical assistance or make lifestyle changes. The goal of this study is to assess people's knowledge, attitudes and practices regarding GERD. In Pakistan, most people have good knowledge of GERD, but there's still a knowledge gap with important public health implications. Greater awareness and education are needed to improve GERD management and health outcomes for those affected. The authors of the original article developed this summary to help patients, caregivers, patient advocates, healthcare professionals, policymakers and insurance providers to understand the results of their study.
- 6 June 2024
- Published by Taylor & Francis in Future Science OA
- Vol. 10 (1) , 2359843
Open AccessAnalysis of attitudes and practices toward gastroesophageal reflux disease among the general population of Pakistan
This summary presents the findings of a survey conducted to gauge people's understanding, attitudes and behaviors concerning gastroesophageal reflux disease (GERD). GERD is a condition involving the movement of stomach contents back into the esophagus or mouth, which can lead to the development of symptoms or complications. Common risk factors associated with the emergence of GERD symptoms, such as heartburn and the regurgitation of stomach contents into the oropharynx, include smoking, consumption of fatty and spicy foods and meal timing. While people are aware of these risk factors and the signs of GERD, many do not take proactive steps to seek medical assistance or make lifestyle changes. The goal of this study is to assess people's knowledge, attitudes and practices regarding GERD. In Pakistan, most people have good knowledge of GERD, but there's still a knowledge gap with important public health implications. Greater awareness and education are needed to improve GERD management and health outcomes for those affected. The authors of the original article developed this summary to help patients, caregivers, patient advocates, healthcare professionals, policymakers and insurance providers to understand the results of their study.
- Open Access
- 11 September 2022
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 82
Monkey pox: A public health emergency
- 11 September 2022
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 82
Open AccessMonkey pox: A public health emergency
- Open Access
- 8 September 2022
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 82, 104626
Recently FDA-approved drug: A new hope for vitiligo patients?
- 8 September 2022
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 82, 104626
Open AccessRecently FDA-approved drug: A new hope for vitiligo patients?